{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:38:21Z","timestamp":1793619501308,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jinf.2016.02.008","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T01:24:45Z","timestamp":1456363485000},"page":"597-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Use of antibodies neutralizing epithelial cell infection to diagnose patients at risk for CMV Disease after transplantation"],"prefix":"10.1016","volume":"72","author":[{"given":"P.","family":"Blanco-Lobo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mart\u00edn-Gandul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Gentil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Su\u00e1rez-Artacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sobrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"P\u00e9rez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2016.02.008_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eimc.2009.07.008","article-title":"Direct and indirect effects of cytomegalovirus: can we prevent them?","volume":"28","author":"Razonable","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.jinf.2016.02.008_bib2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/TP.0b013e3182115ba2","article-title":"Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment","volume":"91","author":"Benmarzouk-Hidalgo","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2016.02.008_bib3","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","author":"Kumar","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jinf.2016.02.008_bib4","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1128\/AAC.05335-11","article-title":"First face composite-tissue transplant recipient successfully treated for cytomegalovirus infection with preemptive valganciclovir treatment","volume":"55","author":"BenMarzouk-Hidalgo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2016.02.008_bib5","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1099\/vir.0.000203","article-title":"The role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in the allogeneic stem cell transplantation setting","volume":"96","author":"Gimenez","year":"2015","journal-title":"J General Virol"},{"key":"10.1016\/j.jinf.2016.02.008_bib6","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.02.008_bib7","doi-asserted-by":"crossref","first-page":"e59863","DOI":"10.1371\/journal.pone.0059863","article-title":"Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pul128-130-131 complex during primary infection","volume":"8","author":"Lilleri","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2016.02.008_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-0012.2007.00750.x","article-title":"CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis","volume":"22","author":"Bonaros","year":"2008","journal-title":"Clin Transplant"},{"issue":"Pt 4","key":"10.1016\/j.jinf.2016.02.008_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1099\/0022-1317-76-4-741","article-title":"Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues","volume":"76","author":"Sinzger","year":"1995","journal-title":"J General Virol"},{"key":"10.1016\/j.jinf.2016.02.008_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jcv.2011.06.018","article-title":"Serum antibody response to the gH\/gL\/pul128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections","volume":"52","author":"Genini","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jinf.2016.02.008_bib11","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1016\/j.vaccine.2011.09.056","article-title":"Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.02.008_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/vir.0.83523-0","article-title":"Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial\/epithelial cells, but not fibroblasts, early during primary infection","volume":"89","author":"Gerna","year":"2008","journal-title":"J General Virol"},{"key":"10.1016\/j.jinf.2016.02.008_bib13","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jinf.2016.02.008_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/605634","article-title":"Toward the individualization of cytomegalovirus control after solid-organ transplantation: the importance of the \u201cindividual pathogenic balance\u201d","volume":"49","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.02.008_bib15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.02.008_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/TP.0b013e31823c1cd4","article-title":"Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia","volume":"93","author":"Lisboa","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2016.02.008_bib17","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.02.008_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.eimc.2011.05.022","article-title":"Gesitra-seimc\/reipi recommendations for the management of cytomegalovirus infection in solid-organ transplant patients","volume":"29","author":"de la Torre-Cisneros","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.jinf.2016.02.008_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2016.02.008_bib20","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1128\/JVI.79.16.10330-10338.2005","article-title":"Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2016.02.008_bib21","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2008.07.092","article-title":"Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection","volume":"26","author":"Cui","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.02.008_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1432-2277.2009.01017.x","article-title":"A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of cmv infection","volume":"23","author":"Eid","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.jinf.2016.02.008_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/511307","article-title":"Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late cmv disease","volume":"195","author":"La Rosa","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2016.02.008_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2009.02861.x","article-title":"Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients","volume":"10","author":"Eid","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jinf.2016.02.008_bib25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1600-6143.2005.00797.x","article-title":"Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+\/R\u2212 transplant recipients","volume":"5","author":"Humar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jinf.2016.02.008_bib26","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jinf.2016.02.008_bib27","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1128\/JVI.78.18.10023-10033.2004","article-title":"Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes","volume":"78","author":"Hahn","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2016.02.008_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1128\/JVI.01910-07","article-title":"Characterization of the human cytomegalovirus gH\/gL\/ul128-131 complex that mediates entry into epithelial and endothelial cells","volume":"82","author":"Ryckman","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2016.02.008_bib29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s10875-012-9739-3","article-title":"Antibodies against neutralization epitopes of human cytomegalovirus gH\/gL\/pul128-130-131 complex and virus spreading may correlate with virus control in\u00a0vivo","volume":"32","author":"Lilleri","year":"2012","journal-title":"J Clin Immunol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344531600058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344531600058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:16Z","timestamp":1759008196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016344531600058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S016344531600058X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.02.008","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of antibodies neutralizing epithelial cell infection to diagnose patients at risk for CMV Disease after transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}